Advertisement

Related Videos

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Mar
19
Today In Oncology
Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
PSMA PET-CT Scan Reduces Need for Prostate Cancer Biopsies
New AACR President-Elect and Board Members Announced
Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer (1)
Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo